Impact of Nanoparticles on Brain Health: An Up to Date Overview.
| Title: | Impact of Nanoparticles on Brain Health: An Up to Date Overview. |
|---|---|
| Authors: | Teleanu DM; Emergency University Hospital, Bucharest, Romania, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania. telepapa@hotmail.com.; Chircov C; Faculty of Engineering in Foreign Languages, 060042 Bucharest, Romania. cristina.chircov@yahoo.com.; Department of Science and Engineering of Oxide Materials and Nanomaterials, Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, 011061 Bucharest, Romania. cristina.chircov@yahoo.com.; Grumezescu AM; Department of Science and Engineering of Oxide Materials and Nanomaterials, Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, 011061 Bucharest, Romania. grumezescu@yahoo.com.; ICUB-Research Institute of University of Bucharest, University of Bucharest, 36-46 M. Kogalniceanu Blvd., 050107 Bucharest, Romania. grumezescu@yahoo.com.; Volceanov A; Department of Science and Engineering of Oxide Materials and Nanomaterials, Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, 011061 Bucharest, Romania. avolceanov@yahoo.co.uk.; Teleanu RI; Emergency University Hospital, Bucharest, Romania, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania. raluca.teleanu@umfcd.ro. |
| Source: | Journal of clinical medicine [J Clin Med] 2018 Nov 27; Vol. 7 (12). Date of Electronic Publication: 2018 Nov 27. |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Basel, Switzerland : MDPI AG, [2012]- |
| Abstract: | Nanoparticles are zero-dimensional nanomaterials and, based on their nature, they can be categorized into organic, inorganic, and composites nanoparticles. Due to their unique physical and chemical properties, nanoparticles are extensively used in a variety of fields, including medicine, pharmaceutics, and food industry. Although they have the potential to improve the diagnosis and treatment of brain diseases, it is fundamentally important to develop standardized toxicological studies, which can prevent the induction of neurotoxic effects. The focus of this review is to emphasize both the beneficial and negative effects of nanoparticles on brain health. |
| References: | Prog Neurobiol. 2017 Oct;157:29-48. (PMID: 28743465); Adv Drug Deliv Rev. 2009 Jun 21;61(6):457-66. (PMID: 19386275); Phys Chem Chem Phys. 2015 Nov 14;17(42):27981-95. (PMID: 26024211); Nanomedicine. 2016 Oct;12(7):1833-1842. (PMID: 27039220); J Control Release. 2016 Aug 10;235:291-305. (PMID: 27269730); Dis Model Mech. 2017 May 1;10(5):499-502. (PMID: 28468935); Nanomaterials (Basel). 2018 Sep 18;8(9):. (PMID: 30231587); Int J Pharm. 2018 Nov 15;551(1-2):329-338. (PMID: 30244148); Biomed Pharmacother. 2017 Jun;90:731-739. (PMID: 28419969); Toxicol Appl Pharmacol. 2016 May 15;299:1-2. (PMID: 26908175); Part Fibre Toxicol. 2018 Jul 3;15(1):28. (PMID: 29970116); Adv Drug Deliv Rev. 2011 May 30;63(6):441-55. (PMID: 21118707); J Nanobiotechnology. 2016 Jul 25;14(1):60. (PMID: 27455834); Reprod Toxicol. 2017 Sep;72:129-135. (PMID: 28627392); Rev Environ Contam Toxicol. 2017;242:61-104. (PMID: 27718008); Sci Rep. 2018 Feb 9;8(1):2760. (PMID: 29426889); Nanoscale Res Lett. 2017 Dec;12(1):478. (PMID: 28774157); Adv Drug Deliv Rev. 2012 Oct;64(13):1363-84. (PMID: 22917779); J Food Drug Anal. 2014 Mar;22(1):147-160. (PMID: 24673911); J Control Release. 2017 Sep 10;261:187-198. (PMID: 28684169); Adv Drug Deliv Rev. 2018 Jul;132:33-56. (PMID: 29964080); Int J Mol Sci. 2014 Mar 18;15(3):4795-822. (PMID: 24646916); J Control Release. 2018 Jan 28;270:290-303. (PMID: 29269142); Nano Today. 2011 Dec;6(6):585-607. (PMID: 23293661); Neurochem Int. 2017 Sep;108:361-371. (PMID: 28527632); Talanta. 2018 Jul 1;184:537-556. (PMID: 29674080); Biomed Res Int. 2014;2014:498420. (PMID: 25165707); Nanotechnology. 2015 Feb 13;26(6):062002. (PMID: 25611515); Biomaterials. 2017 Jun;129:28-36. (PMID: 28324863); Beilstein J Nanotechnol. 2016 Apr 29;7:645-54. (PMID: 27335754); Chem Biol Interact. 2018 Nov 1;295:1-12. (PMID: 30048623); Nanomaterials (Basel). 2017 Feb 22;7(2):. (PMID: 28336883); Nanomedicine. 2016 Feb;12(2):333-51. (PMID: 26707820); Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3225-3230. (PMID: 29531058); Biomaterials. 2017 May;127:97-106. (PMID: 28284105); Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165260. (PMID: 31699365); Ther Deliv. 2017 Oct;8(10):915-928. (PMID: 28944741); Theranostics. 2018 Feb 5;8(6):1481-1493. (PMID: 29556336); J Control Release. 2018 Sep 10;285:212-229. (PMID: 30009891); Curr Opin Syst Biol. 2017 Jun;3:67-76. (PMID: 29057378); Pharmacol Ther. 2018 Nov;191:23-42. (PMID: 29807056); J Trace Elem Med Biol. 2016 Dec;38:53-63. (PMID: 27056797); Neuropharmacology. 2018 Jun;135:139-150. (PMID: 29481916); Anal Biochem. 2016 Nov 1;512:8-17. (PMID: 27523645); Nanomaterials (Basel). 2018 Aug 31;8(9):. (PMID: 30200373); Nanomedicine. 2018 Feb;14(2):609-618. (PMID: 29248676); Biochim Biophys Acta Gen Subj. 2017 Jun;1861(6):1515-1520. (PMID: 28017683); Toxics. 2017 Oct 17;5(4):. (PMID: 29051461); Nanomaterials (Basel). 2015 Aug 19;5(3):1351-1365. (PMID: 28347068); J Nanobiotechnology. 2014 Feb 03;12:5. (PMID: 24491160); Int J Biol Macromol. 2018 Apr 1;109:27-35. (PMID: 29247729); Ageing Res Rev. 2018 Mar;42:72-85. (PMID: 29288112); Photodiagnosis Photodyn Ther. 2017 Sep;19:67-72. (PMID: 28552731); Trends Biotechnol. 2017 Oct;35(10):937-953. (PMID: 28666544); Int J Pharm. 2018 Jul 10;545(1-2):84-92. (PMID: 29715532); Adv Neurobiol. 2017;18:143-158. (PMID: 28889266); Nanomedicine. 2018 Nov;14(8):2609-2618. (PMID: 30171904); Colloids Surf B Biointerfaces. 2016 Sep 1;145:8-13. (PMID: 27131092); Colloids Surf B Biointerfaces. 2019 Jan 1;173:27-35. (PMID: 30261346); Neurochem Int. 2016 May;95:100-8. (PMID: 26550708); Am J Med. 2018 Aug;131(8):874-882. (PMID: 29371158); Biomaterials. 2019 Mar;197:229-243. (PMID: 30677555); Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):256-276. (PMID: 27496705); Biomaterials. 2018 Sep;178:193-203. (PMID: 29936153); Micromachines (Basel). 2017 Aug 28;8(9):. (PMID: 30400452); J Nanosci Nanotechnol. 2009 Aug;9(8):4996-5007. (PMID: 19928180); Int J Pharm. 2017 Jun 15;525(1):237-248. (PMID: 28432017); Adv Healthc Mater. 2018 Feb;7(4):. (PMID: 29193848); Int J Pharm. 2018 May 30;543(1-2):179-189. (PMID: 29555442); Molecules. 2016 Dec 15;21(12):. (PMID: 27983701); Int J Nanomedicine. 2011;6:1117-27. (PMID: 21698080); Curr Med Chem. 2014;21(37):4200-14. (PMID: 25039776); J Control Release. 2016 Oct 28;240:504-526. (PMID: 27292178); J Control Release. 2016 Aug 10;235:34-47. (PMID: 27208862); Colloids Surf B Biointerfaces. 2018 Dec 1;172:708-717. (PMID: 30245296); Adv Exp Med Biol. 2018;1048:227-250. (PMID: 29453542) |
| Contributed Indexing: | Keywords: brain diseases; brain health; brain tumors; diagnosis; inorganic nanoparticles; nanoparticles; neurodegenerative disorders; organic nanoparticles; treatment; zero-dimensional |
| Entry Date(s): | Date Created: 20181130 Latest Revision: 20231005 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC6306759 |
| DOI: | 10.3390/jcm7120490 |
| PMID: | 30486404 |
| Database: | MEDLINE |
Journal Article; Review